Compounds > 5-hydroxymethylcytosine
Page last updated: 2024-08-25

5-hydroxymethylcytosine and Colonic Neoplasms

5-hydroxymethylcytosine has been researched along with Colonic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hauptman, N; Jevšinek Skok, D1
Ebenstein, Y; Gilat, N; Michaeli, Y; Nifker, G; Shahal, T; Shwartz, A; Tabachnik, T; Torchinsky, D; Zirkin, S1
Bachman, M; Carroll, T; Colin, L; de Bony, EJ; Defrance, M; Delatte, B; Dunning, MJ; Fuks, F; Halim, S; Ibrahim, AE; Ito, Y; Krueger, F; Lynch, AG; Murrell, A; Silva, AL; Stark, R; Stojic, L; Ten Hoopen, R; Uribe-Lewis, S; Vowler, SL1
Bissonnette, MB; Butun, F; Chapman, CG; Chuang, A; Godley, LA; Kwon, JH; Madzo, J; Mariani, CJ; Meckel, K; Wu, F1
Choi, YH; Kim, HS; Moon, JW; Park, SH; Seo, JS1
Argani, P; Chaux, A; De Marzo, AM; Esopi, DM; Gerber, J; Haffner, MC; Iacobuzio-Donahue, C; Meeker, AK; Nelson, WG; Netto, GJ; Pellakuru, LG; Toubaji, A; Yegnasubramanian, S1

Other Studies

6 other study(ies) available for 5-hydroxymethylcytosine and Colonic Neoplasms

ArticleYear
Steadfast Toll Like Receptor 4 (
    Genes, 2023, 08-17, Volume: 14, Issue:8

    Topics: Cell-Free Nucleic Acids; Colonic Neoplasms; Health Status; Humans; Toll-Like Receptor 4

2023
Single-molecule quantification of 5-hydroxymethylcytosine for diagnosis of blood and colon cancers.
    Clinical epigenetics, 2017, Volume: 9

    Topics: 5-Methylcytosine; Colonic Neoplasms; DNA, Neoplasm; Epigenesis, Genetic; Hematologic Neoplasms; Humans; Microscopy, Fluorescence; Sensitivity and Specificity; Single Molecule Imaging

2017
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.
    Genome biology, 2015, Apr-01, Volume: 16

    Topics: 5-Methylcytosine; Cell Proliferation; Colonic Neoplasms; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Proto-Oncogene Proteins

2015
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
    Scientific reports, 2015, Dec-03, Volume: 5

    Topics: 5-Methylcytosine; Adenocarcinoma; Binding Sites; Cell Differentiation; Cell Line, Tumor; Colon; Colonic Neoplasms; Cytosine; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Mixed Function Oxygenases; Proto-Oncogene Proteins; Transcription Factors

2015
Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
    BMC cell biology, 2017, 02-27, Volume: 18, Issue:1

    Topics: 5-Methylcytosine; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Mixed Function Oxygenases; Monoterpenes; Neoplasm Proteins; Proto-Oncogene Proteins; RNA, Messenger; Time Factors; Tropolone; Ubiquitin-Protein Ligases

2017
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
    Oncotarget, 2011, Volume: 2, Issue:8

    Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differentiation; Colonic Neoplasms; Cytosine; Down-Regulation; Embryo, Mammalian; Female; Gestational Age; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Stem Cells

2011